Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trialsVlado Perkovic, Bruce Neal, Dick de Zeeuw et al.|The Lancet Diabetes & Endocrinology|2018Cited by 642